All news 28.03.2019

THE TEAM OF RADIOTHERAPY DEPARTMENT AND RADIOSURGERY TOOK PART IN THE “FIRST NATIONAL CONFERENCE OF THE BULGARIAN SOCIETY FOR DERMATOLOGIC SURGERY”

Print

Dr. Ivan Gerogiev, Dr. Milen Markov and Dr. Nedyalka Velikova presented their 3-year experience in the treatment of patients with advanced skin tumours.

The First National Conference of the Bulgarian Society for Dermatologic Surgery took place on 15-16 March 2019 at the Marinela Hotel.

The organizer of the scientific forum was the Bulgarian Society for Dermatologic Surgery (BSDS) and the objective of the congress was to leave a door ajar among all specialties dealing with diagnosis and treatment of skin tumours and neoplastic diseases of various genesis and the innovations in the area of dermatologic aesthetics/surgery. 

A team of Acibadem City Clinic – Oncology Centre involving Dr. Ivan Georgiev, Dr. Nedyalka Velikova and Dr. Milen Markov had a presentation under the title: Cases Trial in Radiotherapy with Advanced Facial Skin Tumours with Intensity Modulated Techniques. Advanced facial skin tumours are a specific interdisciplinary problem difficult for treatment not only that it is close to a lot of organs /eye lenses, eyes, eye nerves, cochlea, ear canal, cranial nerves, etc./ but it is usually impossible to achieve radical oncology treatment combined with desired cosmetic results.

The specialists from Radiotherapy Department at Acibadem City Clinic – Oncology Centre presented their 3-year experience in the treatment and observation of patients with advanced facial skin tumours through high- intensity modulated radiotherapy technology /IMRT/ with excellent oncological and aesthetic results. The advantage of IMRT treatment is that it allows you to distribute the dosage homogenously in smaller ranges minimising the radiation dose on other adjacent organs and reducing the complications in adjacent tissues.  

Further information about the radiotherapy technologies that are performed at Acibadem City Clinic – Oncology Centre you can find HERE.